3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
16
Hodgkin Disease
13
Lymphoma, Non-Hodgkin
11
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma
8
Leukemia, Biphenotypic, Acute
8
Leukemia
8
Burkitt Lymphoma
7
Breast Neoplasms
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neuroblastoma
5
Neoplasms
5
Lymphoma, Mantle-Cell
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hematologic Neoplasms
5
Triple Negative Breast Neoplasms
4
Sarcoma
4
Rhabdomyosarcoma
4
Multiple Myeloma
4
Lymphoma, Follicular
4
Anemia, Refractory, with Excess of Blasts
4
Medulloblastoma
3
Leukemia, Myelomonocytic, Chronic
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Interventions
Oxaliplatin
27
Fluorouracil
23
Leucovorin
22
Cetuximab
22
Bevacizumab
21
Nivolumab
16
Capecitabine
16
Irinotecan
15
pembrolizumab
11
Magnetic Resonance Spectroscopy
11
Specimen Handling
10
encorafenib
8
Folfox protocol
7
trifluridine tipiracil drug combination
6
Ipilimumab
6
Exercise
6
fludarabine
5
cemiplimab
5
Trastuzumab
5
Gemcitabine
5
Cyclophosphamide
5
Cisplatin
5
Blood Specimen Collection
5
Biopsy
5
regorafenib
4
pertuzumab
4
adagrasib
4
Trifluridine
4
Pemetrexed
4
Immune Checkpoint Inhibitors
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Filgrastim
×
1 year
×
Clear all
No trials found.